Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors
Miguel Sampedro‐Núñez(Hospital Universitario de La Princesa), Justo P. Castaño(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Manuel D. Gahete(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Michael D. Culler(Ipsen (United States)), Magdalena Adrados(Hospital Universitario de La Princesa), Mónica Marazuela(Centro de Investigación Biomédica en Red), Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), Alicia Villa-Osaba(University of Córdoba), Ana M. Ramos‐Leví(Hospital Universitario de La Princesa), Ana Serrano-Somavilla(Hospital Universitario de La Princesa), Elena Martín‐Pérez(Hospital Universitario de La Princesa), Raúl M. Luque(Instituto de Salud Carlos III)
Cited by 45
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
|The Journal of Clinical Endocrinology & Metabolism|2019|363
Does gut hormone PYY3–36 decrease food intake in rodents?
|Nature|2004|295